Novavax's Nuvaxovid Approved in US, EU, Japan for 2026-2027 Season

RegulatoryapprovedNuvaxovidPositive

AI Analysis

Summary

Novavax's Nuvaxovid vaccine has received regulatory approval in the US, EU, and Japan for the 2026-2027 season. This represents a significant regulatory milestone for the company's respiratory vaccine candidate.

Outcome Details

Nuvaxovid approved in US, EU, and Japan for 2026-2027 season

Importance:8/10

Sentiment:

0.80

FDA approvalvaccineregulatoryseasonal

Related Companies

$SNY

Read the original article

Published by yahoo_finance on August 28, 2026 1:04 PM

Read Original